29 July 2024 - This is the third indication for Vabysmo, in addition to neovascular or 'wet' age-related macular degeneration and diabetic macular oedema.

Roche Canada is pleased to announce today that Health Canada has authorised Vabysmo (faricimab injection) for the treatment of macular oedema secondary to retinal vein occlusion.

Read Roche press release